https://www.moneycontrol.com/news/business/wockhardt-soars-19-on-completion-of-phase-3-study-of-pneumonia-drug-11886171.html
0
0
12/11/23 at 7:12am
Organization
Moneycontrol
Author
Neethi Rojan
40 words
0
Comments
Wockhardt's Nafithromycin was evaluated in multicentre double-blind Phase 3 pneumonia study and its three-day course was as effective as seven-day therapy with Moxifloxcain
You are the first to view
Create an account
or login to join the discussion